Skip to Main Content

Paper Details

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
PLoS One
46
2020
COVID-, COVID-19, SARS, SARS-, SARS-CoV, SARS-CoV-2, acute kidney injury, cardiac injury, human, melatonin, multiorgan failure, patients, pirfenidone, pulmonary complications, respiratory distress, respiratory symptoms, sepsis, septic shock
Author NameAffiliation
Narcis Fernandez-FuentesUniversitat de Vic-Universitat Central de Catalunya
Narcis Fernandez-FuentesUniversitat de Vic-Universitat Central de Catalunya
Baldo OlivaUniversitat Pompeu Fabra
  • 1 - 3

Datasets

Release 1.2